"Towards the targeted therapy for triple negative breast cancer using nanoparticles, iPeps and CRISPR-dCas9 technology"
Seminar: Curs de formació continuada en investigació
Next Thursday July 12th within our "curs de formació continuada en investigació" we are hosting the following seminar:
Speaker: Anabel Sorolla Bardaji, PhD
From Harry Perkins Institute of Medical Research-The University of Western Australia Perth, Australia;
who will give a talk entitled "Towards the targeted therapy for triple negative breast cancer using nanoparticles, iPeps and CRISPR-dCas9 technology"
Place: Room 0.22 Unitat Docent HUAV (Annex)
Time: 12:00
Host: Dr. M. Alba Sorolla. Should anybody wish to meet privately with the speaker, please call Alba (3747) in advance.
EVERYBODY IS WELCOME
